BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 26655422)

  • 1. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
    Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
    Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort study.
    Román M; Rué M; Sala M; Ascunce N; Baré M; Baroja A; De la Vega M; Galcerán J; Natal C; Salas D; Sánchez-Jacob M; Zubizarreta R; Castells X;
    PLoS One; 2013; 8(12):e83121. PubMed ID: 24376649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study.
    Nederend J; Duijm LE; Voogd AC; Groenewoud JH; Jansen FH; Louwman MW
    Breast Cancer Res; 2012 Jan; 14(1):R10. PubMed ID: 22230363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network.
    Lynge E; Ponti A; James T; Májek O; von Euler-Chelpin M; Anttila A; Fitzpatrick P; Frigerio A; Kawai M; Scharpantgen A; Broeders M; Hofvind S; Vidal C; Ederra M; Salas D; Bulliard JL; Tomatis M; Kerlikowske K; Taplin S;
    Eur J Cancer; 2014 Jan; 50(1):185-92. PubMed ID: 24041876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in the management of the axilla in screen-detected ductal carcinoma in situ: evidence from the UK NHS breast screening programme audit of screen detected DCIS.
    Nicholson S; Hanby A; Clements K; Kearins O; Lawrence G; Dodwell D; Bishop H; Thompson A;
    Eur J Surg Oncol; 2015 Jan; 41(1):86-93. PubMed ID: 25441934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of ductal carcinoma in situ in women undergoing screening mammography.
    Ernster VL; Ballard-Barbash R; Barlow WE; Zheng Y; Weaver DL; Cutter G; Yankaskas BC; Rosenberg R; Carney PA; Kerlikowske K; Taplin SH; Urban N; Geller BM
    J Natl Cancer Inst; 2002 Oct; 94(20):1546-54. PubMed ID: 12381707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in incidence and tumour grade in screen-detected ductal carcinoma in situ and invasive breast cancer.
    Luiten JD; Voogd AC; Luiten EJT; Duijm LEM
    Breast Cancer Res Treat; 2017 Nov; 166(1):307-314. PubMed ID: 28748346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
    Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
    Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
    Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
    Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
    Elshof LE; Schaapveld M; Rutgers EJ; Schmidt MK; de Munck L; van Leeuwen FE; Wesseling J
    Breast Cancer Res; 2017 Mar; 19(1):26. PubMed ID: 28274272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening program.
    Hofvind S; Lee CI; Elmore JG
    Breast Cancer Res Treat; 2012 Aug; 135(1):291-9. PubMed ID: 22833199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of aggressiveness: risk of progression to invasive breast cancer by mammographic features of calcifications in screen-detected ductal carcinoma in situ.
    Lilleborge M; Falk RS; Hovda T; Holmen MM; Ursin G; Hofvind S
    Acta Radiol; 2022 May; 63(5):586-595. PubMed ID: 33887963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection Rates of Ductal Carcinoma in Situ with Biennial Digital Mammography Screening: Radiologic Findings Support Pathologic Model of Tumor Progression.
    Weigel S; Khil L; Hense HW; Decker T; Wellmann J; Heidrich J; Sommer A; Heidinger O; Heindel W
    Radiology; 2018 Feb; 286(2):424-432. PubMed ID: 29106821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should breast screening programmes limit their detection of ductal carcinoma in situ?
    Evans AJ; Blanks RG
    Clin Radiol; 2002 Dec; 57(12):1086-9. PubMed ID: 12475533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncalcified Ductal Carcinoma In Situ (DCIS): Rate and Predictors of Upgrade to Invasive Carcinoma.
    Lamb LR; Kim G; Oseni TO; Bahl M
    Acad Radiol; 2021 Mar; 28(3):e71-e76. PubMed ID: 32222328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.
    Gangnon RE; Sprague BL; Stout NK; Alagoz O; Weedon-Fekjær H; Holford TR; Trentham-Dietz A
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):905-12. PubMed ID: 25787716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.
    Comstock CE; Gatsonis C; Newstead GM; Snyder BS; Gareen IF; Bergin JT; Rahbar H; Sung JS; Jacobs C; Harvey JA; Nicholson MH; Ward RC; Holt J; Prather A; Miller KD; Schnall MD; Kuhl CK
    JAMA; 2020 Feb; 323(8):746-756. PubMed ID: 32096852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT.
    Duffy S; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith R; Evans A; Blyuss O; Johns L; Ellis I; Sasieni P; Wale C; Myles J; Moss S
    Health Technol Assess; 2020 Oct; 24(55):1-24. PubMed ID: 33141657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection of breast cancer through population-based mammographic screening in Asian women: a comparison study between screen-detected and symptomatic breast cancers.
    Chuwa EW; Yeo AW; Koong HN; Wong CY; Yong WS; Tan PH; Ho JT; Wong JS; Ho GH
    Breast J; 2009; 15(2):133-9. PubMed ID: 19292798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.